Loading…
Reported covered position: Deputy Chief of Staff and Legislative Director, Rep. Josh Gottheimer; Legislative Assistant, Sen. Sherrod Brown; Senior Legislative Assistant, Rep. Donald Norcross; Legislative Assistant, Rep. Rob Andrews
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BIOHAVEN PHARMACEUTICALS, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HADRON ENERGY, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Source: Senate LDA
| ST. GEORGES UNIVERSITY |
| 7 |
| 2025–2026 |
| SYNOPSYS, INC. | 7 | 2025–2026 |
| NAPATREE TECHNOLOGY, LLC | 6 | 2025–2026 |
| NOVARTIS | 6 | 2025–2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 6 | 2025–2026 |
| ATLANTIC COAST CONFERENCE | 5 | 2025–2026 |
| PARTICULA GROUP INC. | 5 | 2026 |
| THE NATIONAL ASSOCIATION FOR AMATEUR RADIO | 5 | 2025–2026 |
| VIASAT, INC. | 5 | 2025–2026 |
| ASSOCIATION OF AMERICAN UNIVERSITIES | 4 | 2025–2026 |
| CORVENT MEDICAL, INC. | 4 | 2026 |
| MANHATTAN ASSOCIATES, INC. | 4 | 2026 |
| PRIMO CENTER FOR WOMEN AND CHILDREN | 4 | 2025–2026 |
| SCHWEIGER DERMATOLOGY GROUP | 4 | 2025–2026 |
| ASSOCIATION FOR ADVANCING AUTOMATION | 3 | 2026 |
| PATH ROBOTICS | 3 | 2026 |
| AURA SUB, LLC | 2 | 2025 |
| HADRON ENERGY, INC. | 2 | 2026 |
| SICK PRODUCT & COMPETENCE CENTER AMERICAS, LLC | 2 | 2026 |
| TRUCK TRAILER MANUFACTURERS ASSOCIATION, INC. | 2 | 2026 |
| TTX COMPANY | 2 | 2026 |
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Department of Homeland Security Appropriations Act, 2026
Client: VIASAT, INC. · Firm: DLA PIPER LLP (US)
Air Force procurement issues. Cybersecurity and orbital debris issues. Department of Defense Appropriations Act, FY2027, provisions regarding commercial satellites. H.R. 4213, Department of Homeland Security Appropriations Act, FY2026, provisions regarding commercial satellites. Department of Homeland Security Appropriations Act, FY2027, provisions regarding commercial satellites.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
National Commission on Robotics Act
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act.
National Commission on Robotics Act
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
National Commission on Robotics Act
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334, National Commission on Robotics Act. H.R. 8189, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025.
National Commission on Robotics Act
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
National Commission on Robotics Act
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 9129, GUARD Act of 2026.
National Commission on Robotics Act
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334, National Commission on Robotics Act.
American Security Robotics Act of 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
American Security Robotics Act of 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
American Security Robotics Act of 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334, National Commission on Robotics Act. H.R. 8189, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025.
National Defense Authorization Act for Fiscal Year 2027
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 9129, GUARD Act of 2026.
National Defense Authorization Act for Fiscal Year 2027
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act.
National Defense Authorization Act for Fiscal Year 2027
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
National Defense Authorization Act for Fiscal Year 2027
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
BUILD America 250 Act
Client: TRUCK TRAILER MANUFACTURERS ASSOCIATION, INC. · Firm: DLA PIPER LLP (US)
Policies affecting the transportation sector. Surface transportation reauthorization (draft legislation). H.R. 8870, BUILD America 250 Act.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 9129, GUARD Act of 2026.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: PRIMO CENTER FOR WOMEN AND CHILDREN · Firm: DLA PIPER LLP (US)
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: PRIMO CENTER FOR WOMEN AND CHILDREN · Firm: DLA PIPER LLP (US)
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Department of Homeland Security Appropriations Act, 2027
Client: MANHATTAN ASSOCIATES, INC. · Firm: DLA PIPER LLP (US)
H.R. 9310, Department of Homeland Security Appropriations Act for FY2027, provisions regarding funding for FEMA.
Department of Homeland Security Appropriations Act, 2027
Client: MANHATTAN ASSOCIATES, INC. · Firm: DLA PIPER LLP (US)
H.R. 9310, Department of Homeland Security Appropriations Act for FY2027, provisions regarding funding for FEMA.
Department of Homeland Security Appropriations Act, 2027
Client: VIASAT, INC. · Firm: DLA PIPER LLP (US)
Air Force procurement issues. Cybersecurity and orbital debris issues. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions regarding commercial satellites. H.R. 9310, Department of Homeland Security Appropriations Act, FY2027, provisions regarding commercial satellites.
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
340B drug discount program. General issues related to health care. H.R. 946, ORPHAN Cures Act. Issues related to FDA drug review, including PDUFA.
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Department of Defense Appropriations Act, 2027
Client: NAPATREE TECHNOLOGY, LLC · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
Department of Defense Appropriations Act, 2027
Client: GRVTY, INC. · Firm: DLA PIPER LLP (US)
Federal funding and policies related to the use of AI, cyber and data analytics. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions on funding for AI, cyber and data analytics
Department of Defense Appropriations Act, 2027
Client: GRVTY, INC. · Firm: DLA PIPER LLP (US)
Federal funding and policies related to the use of AI, cyber and data analytics. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions on funding for AI, cyber and data analytics
Department of Defense Appropriations Act, 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Department of Defense Appropriations Act, 2027
Client: NAPATREE TECHNOLOGY, LLC · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
Department of Defense Appropriations Act, 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Department of Defense Appropriations Act, 2027
Client: VIASAT, INC. · Firm: DLA PIPER LLP (US)
Air Force procurement issues. Cybersecurity and orbital debris issues. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions regarding commercial satellites. H.R. 9310, Department of Homeland Security Appropriations Act, FY2027, provisions regarding commercial satellites.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRIMO CENTER FOR WOMEN AND CHILDREN · Firm: DLA PIPER LLP (US)
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PRIMO CENTER FOR WOMEN AND CHILDREN · Firm: DLA PIPER LLP (US)
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Student Athlete Fairness and Enforcement Act
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334, National Commission on Robotics Act. H.R. 8189, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025.
American Security Robotics Act of 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
American Security Robotics Act of 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Protect College Sports Act of 2026
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Protect College Sports Act of 2026
Client: ATLANTIC COAST CONFERENCE · Firm: DLA PIPER LLP (US)
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
National Commission on Robotics Act
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act.
National Commission on Robotics Act
Client: ASSOCIATION FOR ADVANCING AUTOMATION · Firm: DLA PIPER LLP (US)
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 9129, GUARD Act of 2026.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
National Defense Authorization Act for Fiscal Year 2027
Client: NAPATREE TECHNOLOGY, LLC · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
National Defense Authorization Act for Fiscal Year 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
National Defense Authorization Act for Fiscal Year 2027
Client: NAPATREE TECHNOLOGY, LLC · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
National Defense Authorization Act for Fiscal Year 2027
Client: SYNOPSYS, INC. · Firm: DLA PIPER LLP (US)
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
EPIC Act of 2025
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
S. 832, EPIC Act of 2025. Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
EPIC Act of 2025
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
S. 832, EPIC Act of 2025. Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Give Kids a Chance Act of 2025
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
S. Con. Res. 7, Budget Resolution for FY2025, provisions impacting pharmaceuticals. H. Con. Res. 14, Budget Resolution for FY2025, provisions impacting pharmaceuticals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIONJ, INC. · Firm: DLA PIPER LLP (US)
Public policy matters impacting the life sciences industry. H.R. 1, One Big Beautiful Bill Act, tax and healthcare provisions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIONJ, INC. · Firm: DLA PIPER LLP (US)
Public policy matters impacting the life sciences industry. H.R. 1, One Big Beautiful Bill Act, tax and healthcare provisions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: DLA PIPER LLP (US)
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Amateur Radio Emergency Preparedness Act
Client: THE NATIONAL ASSOCIATION FOR AMATEUR RADIO · Firm: DLA PIPER LLP (US)
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Mikaela Naylon Give Kids a Chance Act
Client: BIOTECHNOLOGY INNOVATION ORGANIZATION · Firm: DLA PIPER LLP (US)
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: NOVARTIS · Firm: DLA PIPER LLP (US)
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: BOSTON DYNAMICS, INC. · Firm: DLA PIPER LLP (US)
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, issues related to unmanned ground systems. Federal funding related to robotics via reconciliation. Engagement with Office of Science and Technology Policy, National Security Council and Department of Defense regarding a national robotics strategy.
Advocacy for design and development funding and federal adoption of micro modular nuclear reactor technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHWEIGER DERMATOLOGY GROUP via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Medicare physician fee schedule issues.
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · third_quarter · 3T
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ADVANCING AUTOMATION via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 9129, GUARD Act of 2026.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SICK PRODUCT & COMPETENCE CENTER AMERICAS, LLC via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
PATH ROBOTICS via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SYNOPSYS, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRVTY, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Federal funding and policies related to the use of AI, cyber and data analytics. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions on funding for AI, cyber and data analytics
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies and proposals related to truck size and weight issues. Surface Transportation Board reauthorization. Polices and proposals related to the railroad industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORVENT MEDICAL, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIONJ, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Public policy matters impacting the life sciences industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMO CENTER FOR WOMEN AND CHILDREN via DLA PIPER LLP (US)
2026 · third_quarter · Q3
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAPATREE TECHNOLOGY, LLC via DLA PIPER LLP (US)
2026 · third_quarter · Q3
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
IQVIA HOLDINGS, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies related to life science industry and clinical trial reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON DYNAMICS, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of
MANHATTAN ASSOCIATES, INC. via DLA PIPER LLP (US)
2026 · third_quarter · Q3
H.R. 9310, Department of Homeland Security Appropriations Act for FY2027, provisions regarding funding for FEMA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via DLA PIPER LLP (US)
2026 · third_quarter · Q3
340B drug discount program. General issues related to health care. Issues related to FDA drug review, including PDUFA.
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues. IRA implementation.
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2026 · third_quarter · Q3
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TTX COMPANY via DLA PIPER LLP (US)
2026 · third_quarter · RR
Policies and proposals related to truck size and weight issues; Surface Transportation Board reauthorization; polices and proposals related to the railroad industry.
HADRON ENERGY, INC. via DLA PIPER LLP (US)
2026 · third_quarter · RR
Advocacy for design and development funding and federal adoption of micro modular nuclear reactor technology.
PATH ROBOTICS via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD)
SICK PRODUCT & COMPETENCE CENTER AMERICAS, LLC via DLA PIPER LLP (US)
2026 · third_quarter · RR
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2026 · second_quarter · 2A
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATH ROBOTICS via DLA PIPER LLP (US)
2026 · second_quarter · RR
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Medicare policies.
National security issues related to pharmaceutical industry, including supply chain.
S. 832, EPIC Act of 2025. Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
NOVARTIS via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Tariffs and biotechnology issues related to Treasury and competition with China.
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
Tax reform and tax policy.
VIASAT, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Air Force procurement issues. Cybersecurity and orbital debris issues. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions regarding commercial satellites. H.R. 9310, Department of Homeland Security Appropriations Act, FY2027, provisions regarding commercial satellites.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON DYNAMICS, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 8800, National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334/S. 4686, National Commission on Robotics Act. H.R. 8189/S. 4235, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025. H.R. 9129, GUARD Act of 2026.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of
ASSOCIATION FOR ADVANCING AUTOMATION via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. H.R. 8800, National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334/S. 4686, National Commission on Robotics Act.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NAPATREE TECHNOLOGY, LLC via DLA PIPER LLP (US)
2026 · second_quarter · Q2
H.R. 9495/S. 4784, Department of Defense Appropriations Act for FY2027, provisions on defense technology.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BIOHAVEN PHARMACEUTICALS, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IQVIA HOLDINGS, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies related to life science industry and clinical trial reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANHATTAN ASSOCIATES, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
H.R. 9310, Department of Homeland Security Appropriations Act for FY2027, provisions regarding funding for FEMA.
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL ASSOCIATION FOR AMATEUR RADIO via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMO CENTER FOR WOMEN AND CHILDREN via DLA PIPER LLP (US)
2026 · second_quarter · Q2
H.R. 9260/S. 2587, Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNOPSYS, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
H.R. 9495/S. 4784, Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. H.R. 8845, Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GRVTY, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Federal funding and policies related to the use of AI, cyber and data analytics. H.R. 9495, Department of Defense Appropriations Act, FY2027, provisions on funding for AI, cyber and data analytics
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
TRUCK TRAILER MANUFACTURERS ASSOCIATION, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Policies affecting the transportation sector. Surface transportation reauthorization (draft legislation). H.R. 8870, BUILD America 250 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIONJ, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Public policy matters impacting the life sciences industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues. IRA implementation.
340B drug discount program. General issues related to health care. Issues related to FDA drug review, including PDUFA.
CORVENT MEDICAL, INC. via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · second_quarter · Q2
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act. S. 4668, Protect College Sports Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON DYNAMICS, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. National Defense Authorization Act for FY2027, issues related to unmanned ground systems. H.R. 7334, National Commission on Robotics Act. H.R. 8189, American Security Robotics Act. S. 3275, Humanoid ROBOT Act of 2025.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)
MANHATTAN ASSOCIATES, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Department of Homeland Security Appropriations Act for FY2027, provisions regarding funding for FEMA.
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Tariffs.
Tax reform and tax policy.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Trade policies and agreements, including IP protections, and administrative tariff actions.
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
BIOTECHNOLOGY INNOVATION ORGANIZATION via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
340B drug discount program. General issues related to health care. H.R. 946, ORPHAN Cures Act. Issues related to FDA drug review, including PDUFA.
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
GRVTY, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Federal funding and policies related to the use of AI, cyber and data analytics. Department of Defense Appropriations Act, FY2027, provisions on funding for AI, cyber and data analytics
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
IQVIA HOLDINGS, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies related to life science industry and clinical trial reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL ASSOCIATION FOR AMATEUR RADIO via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMO CENTER FOR WOMEN AND CHILDREN via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Departments of Labor, HHS, and Education Appropriations Act, FY2027, funding and provisions for trauma-informed care and mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORVENT MEDICAL, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2026 · first_quarter · 1T
Research security, research funding, and the importance of American research enterprise and higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policy issues related to tokenized assets. H.R. 3633, Digital Asset Market Clarity Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAPATREE TECHNOLOGY, LLC via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Department of Defense Appropriations Act for FY2027, provisions on defense technology.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BIOHAVEN PHARMACEUTICALS, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRUCK TRAILER MANUFACTURERS ASSOCIATION, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Policies affecting the transportation sector. Surface transportation reauthorization (draft legislation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIASAT, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Air Force procurement issues. Cybersecurity and orbital debris issues. Department of Defense Appropriations Act, FY2027, provisions regarding commercial satellites. H.R. 4213, Department of Homeland Security Appropriations Act, FY2026, provisions regarding commercial satellites. Department of Homeland Security Appropriations Act, FY2027, provisions regarding commercial satellites.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNOPSYS, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Department of Defense Appropriations Act, FY2027, provisions regarding advanced digital engineering. Departments of Commerce, Justice, and Science Appropriations Act, FY2027, provisions regarding advanced engineering simulation. NASA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIONJ, INC. via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Public policy matters impacting the life sciences industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · RA
Policy issues related to tokenized assets.
ASSOCIATION FOR ADVANCING AUTOMATION via DLA PIPER LLP (US)
2026 · first_quarter · Q1
Federal policy relating to national strategy for automation and robotics. Engagement with Department of Commerce regarding national robotics strategy. National Defense Authorization Act for FY2027, provisions on automation and robotics. H.R. 7334, National Commission on Robotics Act.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CORVENT MEDICAL, INC. via DLA PIPER LLP (US)
2026 · first_quarter · RR
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
Legislative and regulatory proposals, policies, and appropriations regarding ventilators and remote patient monitoring, federal ventilator stockpiling, and domestic manufacturing.
PARTICULA GROUP INC. via DLA PIPER LLP (US)
2026 · first_quarter · RR
Policy issues related to tokenized assets.
MANHATTAN ASSOCIATES, INC. via DLA PIPER LLP (US)
2026 · first_quarter · RR
Homeland Security appropriations.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
National security issues related to pharmaceutical industry, including supply chain.
Trade policies and agreements, including IP protections, and administrative tariff actions.
NOVARTIS via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Tax reform and tax policy.
Tariffs.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, provisions related to conditions for research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCHWEIGER DERMATOLOGY GROUP via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025. Medicare physician fee schedule issues.
SYNOPSYS, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 4016/S. 2572, Department of Defense Appropriations, FY2026, provisions regarding advanced digital engineering. H.R. 5342/S. 2354, Departments of Commerce, Justice, and Science Appropriations, FY2026, provisions regarding advanced engineering simulation. NASA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON DYNAMICS, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, issues related to unmanned ground systems.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BIONJ, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Public policy matters impacting the life sciences industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAPATREE TECHNOLOGY, LLC via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 4016/S. 2572, Department of Defense Appropriations Act for FY2026, provisions on defense technology.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PRIMO CENTER FOR WOMEN AND CHILDREN via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 5304/S. 2587, Departments of Labor, HHS, and Education Appropriations, FY2026, funding and provisions for trauma-informed care and mental health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL ASSOCIATION FOR AMATEUR RADIO via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IQVIA HOLDINGS, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
H.R. 4016/S. 2572, Department of Defense Appropriations Act for FY2026, provisions on data analytics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRVTY, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Federal funding and policies related to the use of AI, cyber and data analytics. H.R. 4016/S. 2572, Department of Defense, FY2026, provisions on funding for AI, cyber and data analytics
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
VIASAT, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Air Force procurement issues. Cybersecurity and orbital debris issues. H.R. 4016/S. 2572, Department of Defense Appropriations Act, FY2026, provisions regarding commercial satellites. H.R. 4213, Department of Homeland Security Appropriations Act, FY2026, provisions regarding commercial satellites.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INNOVATION ORGANIZATION via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. H.R. 946, ORPHAN Cures Act. H.R. 1262/S. 932, The Give Kids a Chance Act. IRA implementation. 340B. Orphan drugs. Supply chain. Vaccine policy.
BIOHAVEN PHARMACEUTICALS, INC. via DLA PIPER LLP (US)
2025 · fourth_quarter · Q4
Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via DLA PIPER LLP (US)
2025 · third_quarter · Q3
National security issues related to pharmaceutical industry, including supply chain.
Trade policies and agreements, including IP protections, and administrative tariff actions.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
ATLANTIC COAST CONFERENCE via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Legislative and regulatory proposals affecting intercollegiate athletics. H.R. 4312, SCORE Act. S. 2932, Student Athlete Fairness and Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAPATREE TECHNOLOGY, LLC via DLA PIPER LLP (US)
2025 · third_quarter · Q3
H.R. 4016/S. 2572, Department of Defense Appropriations Act for FY2026, provisions on defense technology.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Tax reform and tax policy.
Tariffs.
SYNOPSYS, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
H.R. 4016/S. 2572, Department of Defense Appropriations, FY2026, provisions regarding advanced engineering simulation. H.R. 5342/S. 2354, Departments of Commerce, Justice, and Science Appropriations, FY2026, provisions regarding advanced engineering simulation. NASA funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOHAVEN PHARMACEUTICALS, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GRVTY, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Federal funding and policies related to the use of AI and data analytics using satellite imagery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IQVIA HOLDINGS, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
H.R. 4016/S. 2572, Department of Defense Appropriations Act for FY2026, provisions on data analytics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON DYNAMICS, INC. via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Federal policy and legislation related to supporting the robotics industry and the intersection of robotics with artificial intelligence. H.R. 3838/S. 2296, National Defense Authorization Act for FY2026, issues related to unmanned ground systems. Federal funding related to robotics via reconciliation. Engagement with Office of Science and Technology Policy, National Security Council and Department of Defense regarding a national robotics strategy.
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN UNIVERSITIES via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Research security, research funding, and the importance of American research enterprise and higher education. H.R. 5304/S. 2587, Departments of Labor/HHS/Education Appropriations Act, FY2026, provisions on federal research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE NATIONAL ASSOCIATION FOR AMATEUR RADIO via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies and proposals related to issues applicable to amateur radio. H.R. 1094/S. 459, Amateur Radio Emergency Preparedness Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. GEORGES UNIVERSITY via DLA PIPER LLP (US)
2025 · third_quarter · Q3
Policies regarding higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Trade policies and agreements, including IP protections, and administrative tariff actions.
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
Healthcare provisions in appropriations and budget legislation.
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Issues related to rare disease and treatment. Drug and pricing policies. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 832, EPIC Act of 2025. Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
National security issues related to pharmaceutical industry, including supply chain.
Medicare policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
S. 832, EPIC Act of 2025.
Medicare policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues.
340B drug discount program. General issues related to health care. H.R. 946, ORPHAN Cures Act. Issues related to FDA drug review, including PDUFA.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement, including rebates and prices.
S. 832, EPIC Act of 2025.
Medicare policies.
H.R. 1, One Big Beautiful Bill Act, provisions impacting pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy.
Issues related to rare disease and treatment. Drug and pricing policy. Issues related to the 340B program. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE